(GMAR) First Trust Exchange-Traded - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F4827 • Defined Outcome

GMAR: Stocks, Options, ETFs

The First Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Moderate Buffer ETF - March (GMAR) is designed to provide a buffer against moderate market downturns while participating in potential gains. Under normal market conditions, the fund primarily invests in FLEX® Options linked to the SPDR® S&P 500® ETF Trust (SPY), which tracks the S&P 500 Index. This strategy aims to balance risk and return for investors seeking equity exposure with downside protection. The fund is non-diversified, meaning it can concentrate its investments in a smaller number of securities, which may increase risk.

The funds structure allows it to offer defined outcome exposure to the U.S. equity market. By utilizing FLEX® Options, GMAR seeks to provide a predefined buffer against losses over a specific period, typically the term of the options strategy. This makes it appealing to investors who want to limit potential losses while maintaining upside potential. The ETF is part of a series of funds with varying buffer levels, catering to different risk tolerance levels.

From a technical standpoint, GMAR has shown stable price action, with its 20-day and 50-day moving averages at 38.12 and 37.86, respectively, indicating a modest upward trend. The 200-day moving average at 36.56 suggests longer-term strength. The Average True Range (ATR) of 0.22 reflects low volatility, while the average 20-day volume of 22,289 shares indicates moderate liquidity. The funds last price of 38.08 aligns closely with its short-term moving averages, signaling potential stability in the near term.

Fundamentally, GMAR manages approximately $288.63 million in assets, giving it a solid scale to execute its investment strategy effectively. The funds focus on SPY-linked FLEX® Options ensures tight correlation with the S&P 500, while the buffer feature provides a unique risk management tool for investors. This combination makes GMAR a viable option for those seeking equity exposure with built-in downside protection.

Based on the provided and , the 3-month outlook for GMAR is as follows: - Price Movement: The funds price is expected to remain stable, with potential upside driven by the S&P 500s performance. The close alignment of the 20-day and 50-day moving averages suggests limited near-term volatility. - Volatility: With an ATR of 0.22, GMAR is likely to experience minimal price fluctuations, making it a lower-risk choice for equity exposure. - Volume Trends: Average daily volume is expected to remain moderate, supporting consistent liquidity for investors. - Buffer Effectiveness: The funds buffer feature is anticipated to perform as designed, providing a moderate level of downside protection during market declines. Overall, GMAR is positioned to deliver on its defined outcome strategy, offering investors a balanced approach to equity market participation with managed risk.

Additional Sources for GMAR ETF

GMAR ETF Overview

Market Cap in USD 289m
Category Defined Outcome
TER 0.85%
IPO / Inception 2023-03-17

GMAR ETF Ratings

Growth 5y 59.0%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -1.36
Analysts -
Fair Price Momentum 35.25 USD
Fair Price DCF -

GMAR Dividends

No Dividends Paid

GMAR Growth Ratios

Growth Correlation 3m 25.6%
Growth Correlation 12m 95.8%
Growth Correlation 5y 98.6%
CAGR 5y 11.53%
CAGR/Max DD 5y 2.23
Sharpe Ratio 12m 0.92
Alpha 2.01
Beta 0.46
Volatility 17.82%
Current Volume 126.2k
Average Volume 20d 30.7k
What is the price of GMAR stocks?
As of March 16, 2025, the stock is trading at USD 37.07 with a total of 126,221 shares traded.
Over the past week, the price has changed by -1.54%, over one month by -3.26%, over three months by -1.61% and over the past year by +9.19%.
Is First Trust Exchange-Traded a good stock to buy?
Partly, yes. Based on ValueRay Analyses, First Trust Exchange-Traded (BATS:GMAR) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.97 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GMAR as of March 2025 is 35.25. This means that GMAR is currently overvalued and has a potential downside of -4.91%.
Is GMAR a buy, sell or hold?
First Trust Exchange-Traded has no consensus analysts rating.
What are the forecast for GMAR stock price target?
According to ValueRays Forecast Model, GMAR First Trust Exchange-Traded will be worth about 38.9 in March 2026. The stock is currently trading at 37.07. This means that the stock has a potential upside of +4.96%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 38.9 5%